News

Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board
Climb Bio (CLYM) announced the appointments of Kim Cobleigh Drapkin, CPA, and Bo Cumbo to its Board of Directors. Ms. Drapkin will assume the ...
The Manila Times3d
Solid Biosciences to Participate at Upcoming Investor Conferences
CHARLESTOWN, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a ...
TMCnet9d
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
WELLESLEY HILLS, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of biotech industry veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo to its ...
GlobalData on MSN1mon
Solid Biosciences’ stock soars on early success in DMD gene therapy trial
Solid Biosciences CEO Bo Cumbo said: “Three different measurement methodologies showed what we believe to be a potential best ...
Yahoo Finance3d
Solid Biosciences to Participate at Upcoming Investor Conferences
Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present on Thursday, April 10, 2025, at 2:15 pm ET. A live webcast of the presentation will be available on the ...
Seeking Alpha9d
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of biotech industry veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo to its Board of Directors.
Morningstar1mon
Solid Biosciences to Participate at Upcoming Investor Conferences
Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will participate in a fireside chat on Wednesday, March 12, 2025, at 9:20 am ET. Mr. Cumbo and Dr. Brooks will ...